Log inSign up
CSL Behring
CSL
4,146 posts
Image
user avatar
CSL Behring
CSL
@CSLBehring
We are driven by our promise to help patients lead full lives. See our community guidelines: bit.ly/3QZbZeZ
King of Prussia, PA
cslbehring.com
Joined April 2009
488
Following
9,328
Followers
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Jun 17, 2019
    Patients growing up with a chronic illness have to take charge of their own care at some point. Here are some tips from #SickleCell patients for young adults about to take over their own care. #WorldSickleCellDay2019
    Image
    00:00
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Apr 2, 2018
    We get by with a little help from our #friends. If you have a friend with a #raredisease, here are ways to be truly helpful. @RareDiseases
    Image
    00:00
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Jun 13, 2019
    We join @SCCConsortium @ConquerSCD @SCDAAorg @ASCAA_ @SickleCellUK and others around the world next week for #WorldSickleCellDay2019 Help us raise awareness of this disease by watching and sharing this short video about the impact of #SickleCell cslbehring.com/vita/2018/a-fo…
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Feb 7, 2018
    Hemophilia is complicated, but here's a simple explanation in a short video: Watch it: youtu.be/BoXBuJSURTI #EAHAD18
    Image
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    May 5, 2019
    Students paint with #CSLBehring employees to bring a biotech-themed @muralarts image to life cslbehring.com/vita/2019/mura…
    Image
    00:00
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Mar 8, 2018
    A team of NFL hopefuls raised awareness and money for #rarediseases at this year's NFL combine - a campaign that got its start @PennStateFball with a single athlete: Jesse James @JJames18_ who now plays for the @Steelers! cslbehring.com/vita/20180307-… @UpliftingAth
    Image
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Mar 6, 2023
    Today at #ACC23, Drs. @EliotBrinton and Nihar Desai will discuss the 90-day high-risk window post-AMI and why this time period is critical for patients. Visit Industry-Expert Theater #1 and find more details here: bit.ly/41MMV1a
    Image
    160K
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Apr 29, 2020
    Plasma donations are urgently needed. Find out how it works and why #raredisease patients appreciate the generosity of plasma donors. bit.ly/2xiwkJ8 @IDFCommunity @ipopi_info #donateplasma
    Image
    00:00
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Sep 10, 2019
    Come see us at #ESID2019, 18-21, September, Brussels, Belgium. @CSLBehring is supporting five scientific posters and the Satellite Symposium, “Infections and secondary immunodeficiency in hematologic cancer: identifying patients at risk.” #DrivenbyOurPromise
    Image
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Dec 27, 2021
    Are today's high school students ready to harness #artificialintelligence? To assist, CSL Behring sponsored a boot camp program initiated by @mcuban. bit.ly/3H6uvgK
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Jun 15, 2019
    #DYK that #SickleCell disease can cause vulnerability to infections, organ problems and even stroke? Learn more for #WorldSickleCellDay2019 by watching this quick video spr.ly/6012Eo7O2
    Image
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Apr 12, 2018
    In honor of World #Hemophilia Day, we created a new video for families. It answers the question: When is my child ready to learn to self-infuse? #SharingKnowledgeMakesUsStronger #WHD2018 @wfhemophilia @NHF_Hemophilia
    Image
    00:00
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Apr 6, 2020
    Earlier today we announced an industry alliance with other world-leading plasma companies to accelerate development of a potential hyperimmune immunoglobulin therapy in the fight against the #COVID19 pandemic. Details bit.ly/2Xe9HQF
  • user avatar
    CSL Behring
    CSL
    @CSLBehring
    Jun 23, 2017
    #BREAKING: US FDA approves the first and only subQ preventive therapy for patients w/ hereditary angioedema #HAE. ow.ly/Y25k30cQApp
    Image

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms of Service|Privacy Policy|Cookie Policy|Accessibility|Ads info|© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement